Diagnoptics News

What's new?

Read all news items about the AGE Reader and Diagnoptics.

Successful introduction of the AGE Reader mu

Groningen, the Netherlands – October 22, 2012
The revolutionary AGE Reader mu has been presented for the first time at the EASD conference 2012 in Berlin.

Over 400 healthcare professionals visited the DiagnOptics booth to have a non-invasive demonstration measurement. Their reactions on the AGE Reader mu are very enthusiastic and confirmed the added value of the device in daily clinical use. The AGE Reader mu helps the doctor in answering the question of whether or not to intensify the therapy.

The AGE Reader mu assesses the level of Advanced Glycation Endproducts (AGEs) in tissue. Because of their important role in the development of micro- and macrovasular complications, the measurement of AGEs means a major improvement of diabetes care. The short measurement time, small size and attractive pricelevel make the AGE Reader mu very suitable for daily clinical use.

The AGE Reader mu is a perfect tool for diabetologists and family doctors.

Read more about the AGE Reader mu.

Share this link on:

Latest news items

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The 'AGE Reader mu' is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors. Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.